Companies / South Africa
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
Domestic Vaccine Production Recommences
October 2007 | Company News AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
South Africa is poised to regain the capacity to manufacture vaccines following an announcement by public-private partnership (PPP) the Biovac Institute that it has begun production of small quantities of hepatitis B vaccine for validation and testing by the Medicines Control Council (MCC). BMI expects approval to be put onto a fast track given the strategic value of local vaccine manufacturing capacity, so commercial production could begin before the end of